Boston-based Vertex reported revenue of $3.08 billion, an 11 percent gain from one year ago. That was ahead of analysts’ ...

Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...

Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...

President Donald Trump littered his new “60 Minutes” interview with a wide-ranging assortment of false claims, the vast ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

The undercover drug buys involved fentanyl, methamphetamine and the even deadlier opioid known as carfentanil, according to ...